Every 10-Q that REGIONAL HEALTH PRTYS INC (RHEP) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow RHEP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RHEP filings page.
Regional Health Properties, Inc. reported significantly larger scale operations for the six months ended June 30, 2026, following its shift from a pure landlord to an owner‑operator with three segments: Healthcare Services, Pharmacy Services and Real Estate. Total revenues were $45.6 million, driven mainly by patient care revenue of $26.7 million and new pharmacy revenue of $17.2 million, compared with total revenues of $17.2 million a year earlier.
The company still posted a net loss of $2.0 million for the six‑month period and a stockholders’ equity deficit of $1.7 million, with total liabilities of $65.0 million and total debt of $42.6 million. Cash and restricted cash totaled $4.6 million, and operating activities provided $0.5 million of cash. Management discloses heavy reliance on collections of healthcare and pharmacy receivables and asset sales to fund near‑term needs.
The company’s securities were delisted from NYSE American in 2025 and now trade on the OTCQB, which it states could constrain access to capital. It remains in compliance with debt covenants except for USDA and SBA loans tied to the Southland facility, which are under forbearance agreements through February 1, 2027. Management evaluated its liquidity plans and concluded it is probable the company can meet obligations for at least 12 months after issuance, so the financial statements are prepared on a going‑concern basis.
Regional Health Properties, Inc. reported Q1 2026 revenue of $21.2 million, up sharply from $7.2 million a year earlier, mainly from expanded healthcare operations and the new pharmacy segment. Patient care revenue rose to $12.7 million and pharmacy revenue contributed $7.6 million, while rental revenue declined as one facility shifted from lease to operated status.
The company posted a net loss of $1.2 million, similar to the prior-year loss. Cash used in operating activities was $0.9 million, and unrestricted cash stood at $1.1 million with $10.1 million of net receivables. Total debt was $42.6 million, and management entered forbearance agreements on certain Southland-related USDA and SBA notes. Management concluded it is probable the company can meet obligations for at least twelve months after issuance of these statements.
Regional Health Properties reported Q3 2025 results reflecting its SunLink merger and expanded operations. Revenue rose to $15,138 from $4,225 a year ago, driven by patient care of $9,831, rental revenue of $1,303, and pharmacy revenue of $4,004. Net income was $3,382 versus a loss of $(982) in Q3 2024, aided by a $5,311 gain on bargain purchase.
Total assets were $72,150 and total liabilities $68,997, with stockholders’ deficit improving to $(1,538). Cash was $994 and accounts receivable $7,715. Net cash from operations for the nine months was $(994), investing provided $5,332 (including $5,975 cash acquired), and financing used $(3,818). Debt, net, was $48,578, and the company was in covenant compliance.
The SunLink merger closed on August 14, 2025, issuing 1,595,400 common shares and 1,408,121 Series D preferred shares. The Coosa and Meadowood facilities were classified as held for sale; the Coosa sale closed on November 6, 2025. The common and Series A preferred now trade on OTCQB as RHEP and RHEPA. Shares outstanding were 3,934,677 as of November 13, 2025.